Search clinical trials for: Split thickness skin graft donor site

Total 127297 results

Eli Lilly and Company

Completed

Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With Schizophrenia

Schizophrenic Disorders

Turkey, Finland
Novartis

Completed

Effect of Indacaterol on Inspiratory Capacity and Lung Function in Patients With COPD Versus Placebo and Formoterol

COPD

United Kingdom
Novartis

Completed

Effect of Moderate Hepatic Impairment on the Pharmacokinetics and Metabolism of a Single Dose of Licarbazepine

Healthy

Czech Republic
Novartis

Completed

Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects.

Healthy

United States
Novartis

Completed

A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma

Bronchial Asthma

Germany
Novartis

Completed

Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers

Healthy

Germany
Novartis

Completed

Safety and Tolerability of AQW051 in Elderly Healthy Volunteers.

Healthy

United Kingdom
Novartis

Completed

Effect of Food on the Pharmacokinetics of AQW051 in Japanese Healthy Male Subjects

Healthy

Japan
Novartis

Completed

Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone Under Fasting Conditions in Healthy Volunteers

Healthy

Germany
Novartis

Completed

Effect of Severe Renal Impairment on Pharmacokinetics and Metabolism of a Single Administration of Licarbazepine

Healthy

Czech Republic
Eli Lilly and Company

Completed

Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer

Non-Small Cell Lung Cancer

China
Novartis

Completed

To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy Volunteers

Healthy

India
Novartis

Completed

Study to Explore the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AHT956 in Healthy Subjects

Healthy

Switzerland
Novartis

Completed

Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers

Healthy

Germany
Eli Lilly and Company

Completed

Duloxetine Versus Paroxetine for Major Depression

Major Depressive Disorder

China
Hillel Yaffe Medical Center

Unknown

Feasibility and Outcomes of Older Patients Hospitalization

Cellulitis | Community-Acquired Pneumonia | Exacerbation of Chronic Obstructive Pulmonary Disease | Exacerbation of Chronic Heart Failure
Soroka University Medical Center

Unknown

Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer

Stomach Neoplasms

Israel
Tel-Aviv Sourasky Medical Center

Unknown

Measurements of Skin Physiological Parameters as Mean of Metabolic Assessment (TEMP)

Hungry-Satiation Situation

Israel
Symbollon Pharmaceuticals

Unknown

Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast Pain

Pain | Fibrocystic Disease of Breast | Fibrocystic Changes of Breast | Fibrocystic Mastopathy

United States
Research Unit Of General Practice, Copenhagen

Completed

Implantation of Gold Beads to Relieve Discomfort From Knee Osteoarthritis

Osteoarthritis, Knee

Denmark
Eli Lilly and Company

Completed

Growth Hormone Treatment in Short Children Born Small for Gestational Age

Infant, Small for Gestational Age

Germany
Tel-Aviv Sourasky Medical Center

Unknown

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer

Pancreatic Cancer

Israel
Nordic Bioscience A/S
Novartis

Completed

SMC021A - Absorption, Efficacy and Tolerance in Patients With Osteoarthritis. A Placebo-Controlled 14-Days Study

Osteoarthritis

Denmark
Nordic Bioscience A/S
Novartis

Completed

Pharmacokinetics/Pharmacodynamics of Oral Salmon Calcitonin in Patients With Osteoarthritis

Osteoarthritis

Denmark
VA Puget Sound Health Care System
Dr. Gregory Merrick; Theragenics Corporation

Unknown

I-125 Versus Pd-103 for Medium Risk Prostate Cancer

Prostate Cancer

United States
Bayside Health
The Alfred; Baker Heart Research Institute

Completed

Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome

Marfan Syndrome
Eli Lilly and Company

Completed

Evaluation of Continuous Symptom Treatment of ADHD

Attention Deficit Hyperactivity Disorder

United States
Eli Lilly and Company

Completed

Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD

Attention Deficit Hyperactivity Disorder

China, Mexico, Korea, Republic of
Eli Lilly and Company

Completed

Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia

Schizophrenia

Japan
Eli Lilly and Company

Completed

Managing Acute Schizophrenia, a Comparison Between Two Atypical Antipsychotics

Schizophrenia

China
Eli Lilly and Company

Completed

Comparison of Atomoxetine Plus Either Comparator or Placebo in Children With ADHD Who Haven't Responded to Stimulant Therapy

Attention Deficit Hyperactivity Disorder

United States
Eli Lilly and Company

Completed

Safety Study in Outpatient Japanese Children With ADHD

Attention Deficit Hyperactivity Disorder

Japan
Eli Lilly and Company

Completed

Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression

Bipolar Disorder

United States
Eli Lilly and Company

Completed

Atomoxetine Hydrochloride Versus Placebo in Taiwanese Children and Adolescents With ADHD

Attention Deficit Hyperactivity Disorder

Taiwan
Eli Lilly and Company

Completed

Olanzapine Versus Comparator in the Treatment of Bipolar Disorder

Bipolar Disorder

China
Eli Lilly and Company

Completed

Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia

Schizophrenia

Taiwan
Eli Lilly and Company

Completed

Weight Gain Management in Patients With Schizophrenia

Schizophrenia

Brazil
Eli Lilly and Company

Completed

Assessment of a Weight Management Program for Weight Gain in Patients With Schizophrenia

Schizophrenic Disorders

Korea, Republic of
Eli Lilly and Company

Completed

Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHD

Attention Deficit Hyperactivity Disorder

United States
Eli Lilly and Company

Completed

Combination Therapy in Patients With Depression

Depressive Symptoms

United States
Eli Lilly and Company

Completed

Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder

Bipolar Disorder

United States
Eli Lilly and Company

Completed

Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial

Postmenopausal Osteoporosis

Germany, Spain, Greece, Mexico, Israel, Czech Republic
Eli Lilly and Company

Completed

Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia

Schizophrenia

United States, Russian Federation, Croatia
University of Kansas

Completed

Effects of Modified T'ai Chi on Symptoms in Older Adults With Osteoarthritis

Osteoarthritis
Eli Lilly and Company

Completed

Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia

Schizophrenia

United States, Russian Federation
Eli Lilly and Company

Completed

Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Disorder With Hyperactivity

Russian Federation
Eli Lilly and Company

Completed

Evaluation of the Effects of Duloxetine on Norepinephrine

Major Depressive Disorder

United States
Tel-Aviv Sourasky Medical Center

Unknown

Stereotactic Radiosurgery to the Resection Cavity Following Surgical Removal of Brain Metastasis

Brain Neoplasms

Israel
Mashhad University of Medical Sciences

Completed

Study of Metronidazole and Doxycycline to Treat Oral Lichen Planus and to Compare Their Efficacy With Each Other

Oral Lichen Planus

Iran, Islamic Republic of
Point Therapeutics

Completed

Study of Talabostat and Cisplatin in Advanced Melanoma

Melanoma | Skin Cancer

United States

3

Subscribe